SEB Asset Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
SEB Asset Management's RPRX Position: Q3 2026 in Review
SEB Asset Management reduced its Royalty Pharma (RPRX) stake by 6% in Q3 2026, selling an estimated $1.56M and leaving 416,628 shares worth $24.3M. The position accounts for 0.09% of the portfolio, ranked #189.
SEB Asset Management first reported a position in RPRX in Q1 2026 and has held it in 3 quarters since. The position peaked at $24.8M in Q2 2026. 703 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- SEB Asset Management held 416,628 shares of Royalty Pharma worth $24.3M as of Q3 2026.
- SEB Asset Management sold 26,407 Royalty Pharma shares in Q3 2026, an estimated $1.56M.
- Royalty Pharma made up 0.09% of SEB Asset Management's portfolio in Q3 2026, its #189 holding.
- SEB Asset Management first reported a position in Royalty Pharma in Q1 2026 and has held it in 3 quarters since.
- SEB Asset Management's Royalty Pharma position peaked at $24.8M in Q2 2026.
- 703 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.